Published in Science on October 22, 1982
Compilation of published signal sequences. Nucleic Acids Res (1984) 11.33
Structural analysis of the major immediate early gene of human cytomegalovirus. J Virol (1984) 6.67
Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J Exp Med (1994) 4.01
Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J Virol (1998) 3.98
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74
Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proc Natl Acad Sci U S A (1984) 3.58
Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody. J Virol (1984) 3.53
Identification of a novel herpes simplex virus type 1-induced glycoprotein which complexes with gE and binds immunoglobulin. J Virol (1987) 3.40
The herpes simplex virus type 1 alpha protein ICP27 can act as a trans-repressor or a trans-activator in combination with ICP4 and ICP0. J Virol (1988) 3.33
Association of the herpes simplex virus regulatory protein ICP4 with specific nucleotide sequences in DNA. Nucleic Acids Res (1986) 3.09
Herpes simplex virus glycoprotein D mediates interference with herpes simplex virus infection. J Virol (1989) 3.09
Organization of nonstructural genes of the autonomous parvovirus minute virus of mice. J Virol (1986) 2.82
DNA sequence elements required for regulated expression of the HSV-1 glycoprotein D gene lie within 83 bp of the RNA capsites. Nucleic Acids Res (1983) 2.81
Characterization of a pseudorabies virus glycoprotein gene with homology to herpes simplex virus type 1 and type 2 glycoprotein C. J Virol (1986) 2.79
Localization of epitopes of herpes simplex virus type 1 glycoprotein D. J Virol (1985) 2.71
Fine mapping of antigenic site II of herpes simplex virus glycoprotein D. J Virol (1989) 2.68
Pseudorabies virus gene encoding glycoprotein gIII is not essential for growth in tissue culture. J Virol (1986) 2.47
Analysis of the distribution of charged residues in the N-terminal region of signal sequences: implications for protein export in prokaryotic and eukaryotic cells. EMBO J (1984) 2.43
Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol (1984) 2.36
Detection of Herpes simplex virus DNA by real-time PCR. J Clin Microbiol (2000) 2.29
Expression of herpes simplex virus type 1 glycoprotein D deletion mutants in mammalian cells. J Virol (1988) 2.29
DNA sequence of the gene for pseudorabies virus gp50, a glycoprotein without N-linked glycosylation. J Virol (1986) 2.23
Binding to cells of virosomes containing herpes simplex virus type 1 glycoproteins and evidence for fusion. J Virol (1984) 2.21
Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus. J Virol (1990) 2.17
Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM. J Virol (1998) 2.11
Isolation, characterization, and physical mapping of a pseudorabies virus mutant containing antigenically altered gp50. J Virol (1984) 2.09
Identification of a new glycoprotein of herpes simplex virus type 1 and genetic mapping of the gene that codes for it. J Virol (1986) 2.07
Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D. J Virol (1996) 2.05
High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells. J Virol (1994) 1.97
Identification, sequence, and transcriptional mapping of the major capsid protein gene of the baculovirus Autographa californica nuclear polyhedrosis virus. J Virol (1989) 1.87
Identification of functional regions of herpes simplex virus glycoprotein gD by using linker-insertion mutagenesis. J Virol (1994) 1.85
Fine structure analysis of type-specific and type-common antigenic sites of herpes simplex virus glycoprotein D. J Virol (1984) 1.63
Characterization of the gene encoding herpes simplex virus type 2 glycoprotein C and comparison with the type 1 counterpart. J Virol (1985) 1.60
Molecular cloning, sequencing, and expression of functional bovine herpesvirus 1 glycoprotein gIV in transfected bovine cells. J Virol (1990) 1.57
Glycopeptides of the type-common glycoprotein gD of herpes simplex virus types 1 and 2. J Virol (1983) 1.55
Synthetic glycoprotein D-related peptides protect mice against herpes simplex virus challenge. J Virol (1985) 1.51
Synthesis and processing of glycoprotein D of herpes simplex virus types 1 and 2 in an in vitro system. J Virol (1983) 1.48
Expression of herpes simplex virus glycoproteins in polarized epithelial cells. J Virol (1986) 1.46
Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G. J Virol (1997) 1.43
Amino-terminal sequence of glycoprotein D of herpes simplex virus types 1 and 2. J Virol (1984) 1.42
ICP4-binding sites in the promoter and coding regions of the herpes simplex virus gD gene contribute to activation of in vitro transcription by ICP4. J Virol (1989) 1.40
Influence of asparagine-linked oligosaccharides on antigenicity, processing, and cell surface expression of herpes simplex virus type 1 glycoprotein D. J Virol (1989) 1.38
Antigenic structure of soluble herpes simplex virus (HSV) glycoprotein D correlates with inhibition of HSV infection. J Virol (1997) 1.36
Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. J Virol (1994) 1.36
Disulfide bond structure of glycoprotein D of herpes simplex virus types 1 and 2. J Virol (1992) 1.36
The contribution of cysteine residues to antigenicity and extent of processing of herpes simplex virus type 1 glycoprotein D. J Virol (1988) 1.27
Expression of herpes simplex virus 1 glycoprotein B by a recombinant vaccinia virus and protection of mice against lethal herpes simplex virus 1 infection. Proc Natl Acad Sci U S A (1987) 1.26
Identification of a site on herpes simplex virus type 1 glycoprotein D that is essential for infectivity. J Virol (1990) 1.26
Evidence for translational regulation of herpes simplex virus type 1 gD expression. J Virol (1984) 1.24
Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol (1994) 1.23
Insertion mutants of herpes simplex virus have a duplication of the glycoprotein D gene and express two different forms of glycoprotein D. J Virol (1983) 1.22
Induction of complement-dependent and -independent neutralizing antibodies by recombinant-derived human cytomegalovirus gp55-116 (gB). J Virol (1988) 1.21
Herpes simplex virus gD and virions accumulate in endosomes by mannose 6-phosphate-dependent and -independent mechanisms. J Virol (1998) 1.18
Characterization of the herpes simplex virus type 1 glycoprotein D mRNA and expression of this protein in Xenopus oocytes. Nucleic Acids Res (1983) 1.16
Absence of asparagine-linked oligosaccharides from glycoprotein D of herpes simplex virus type 1 results in a structurally altered but biologically active protein. J Virol (1991) 1.16
Helper T cells induced by an immunopurified herpes simplex virus type I (HSV-I) 115 kilodalton glycoprotein (gB) protect mice against HSV-I infection. J Exp Med (1985) 1.15
Genomic concatemerization/deletion in rotaviruses: a new mechanism for generating rapid genetic change of potential epidemiological importance. J Virol (1993) 1.14
Use of herpes simplex virus and pseudorabies virus chimeric glycoprotein D molecules to identify regions critical for membrane fusion. Proc Natl Acad Sci U S A (2004) 1.12
Mapping of the transcriptional initiation site of the herpes simplex virus type 1 ICP8 gene in infected and transfected cells. J Virol (1987) 1.12
A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine. PLoS One (2011) 1.10
Overexpression in bacterial and identification in infected cells of the pseudorabies virus protein homologous to herpes simplex virus type 1 ICP18.5. J Virol (1991) 1.07
Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function. J Virol (1990) 1.06
Localization of a type-specific antigenic site on herpes simplex virus type 2 glycoprotein D. J Virol (1984) 1.06
Regulation of transcription in vitro from herpes simplex virus genes. J Virol (1986) 1.06
The alpha protein ICP0 does not appear to play a major role in the regulation of herpes simplex virus gene expression during infection in tissue culture. Nucleic Acids Res (1987) 1.06
Viral determinants of the variable sensitivity of herpes simplex virus strains to gD-mediated interference. J Virol (1995) 1.04
Organization of the thymidylate synthase gene of herpesvirus saimiri. J Virol (1986) 1.03
Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope. J Virol (1992) 1.03
Use of synthetic peptides to map the antigenic determinants of glycoprotein D of herpes simplex virus. J Virol (1988) 1.03
Characterization of an equine herpesvirus type 1 gene encoding a glycoprotein (gp13) with homology to herpes simplex virus glycoprotein C. J Virol (1988) 1.00
Native and recombinant herpes simplex virus type 1 envelope proteins induce human immune T-lymphocyte responses. J Virol (1987) 0.99
Molecular cloning of the Aleutian disease virus genome: expression of Aleutian disease virus antigens by a recombinant plasmid. J Virol (1983) 0.99
RNAs transcribed from a 3.6-kilobase SmaI fragment of the short unique region of the herpes simplex virus type 1 genome. J Virol (1983) 0.97
Antibodies against synthetic peptides of herpes simplex virus type 1 glycoprotein D and their capability to neutralize viral infectivity in vitro. J Virol (1988) 0.93
Response of dairy calves to vaccinia viruses that express foreign genes. J Clin Microbiol (1986) 0.93
Herpes simplex virus 2 ICP0 mutant viruses are avirulent and immunogenic: implications for a genital herpes vaccine. PLoS One (2010) 0.92
Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C. J Virol (1992) 0.88
The glycoprotein D (US6) homolog is not essential for oncogenicity or horizontal transmission of Marek's disease virus. J Virol (1998) 0.88
Description of a nonlethal herpes simplex virus type 1 glycoprotein D deletion mutant affecting a site frequently used for PCR. Clin Diagn Lab Immunol (2000) 0.84
Isolation by high-performance liquid chromatography and partial characterization of a 57,000-dalton herpes simplex virus type 1 polypeptide. J Virol (1985) 0.84
Transcription from the BamHI J fragment of herpes simplex virus type 1 (KOS). J Virol (1983) 0.80
Prediction and identification of potential immunodominant epitopes in glycoproteins B, C, E, G, and I of herpes simplex virus type 2. Clin Dev Immunol (2012) 0.78
Bovine herpesvirus glycoprotein D: a review of its structural characteristics and applications in vaccinology. Vet Res (2014) 0.77
Bicistronic DNA vaccines simultaneously encoding HIV, HSV and HPV antigens promote CD8⁺ T cell responses and protective immunity. PLoS One (2013) 0.77
Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C. J Virol (1990) 0.76
Shared ancestry of herpes simplex virus 1 strain Patton with recent clinical isolates from Asia and with strain KOS63. Virology (2017) 0.75
A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature (1980) 8.47
Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions. Proc Natl Acad Sci U S A (1980) 7.77
Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome. Cell (1977) 7.60
Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol (2000) 6.68
Cloning specific segments of the mammalian genome: bacteriophage lambda containing mouse globin and surrounding gene sequences. Proc Natl Acad Sci U S A (1977) 5.28
Separation and characterization of herpes simplex virus type 1 immediate-early mRNA's. J Virol (1979) 5.21
Construction and characterization of a recombinant plasmid encoding the gene for the thymidine kinase of Herpes simplex type 1 virus. Gene (1979) 5.09
Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. J Virol (1999) 4.19
Replication of bacteriophage lambda DNA dependent on the function of host and viral genes. I. Interaction of red, gam and rec. J Mol Biol (1973) 4.04
Characterization of transcription-deficient temperature-sensitive mutants of herpes simplex virus type 1. Virology (1978) 3.87
Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol (1999) 3.80
Effect of brefeldin A on alphaherpesvirus membrane protein glycosylation and virus egress. J Virol (1991) 3.58
An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J (1993) 3.48
Cloning of herpes simplex type 1 DNA fragments in a bacteriophage lambda vector. Science (1979) 3.47
A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis. Proc Natl Acad Sci U S A (2000) 3.45
Herpesviruses use bidirectional fast-axonal transport to spread in sensory neurons. Proc Natl Acad Sci U S A (2001) 3.34
Structures of two spliced herpes simplex virus type 1 immediate-early mRNA's which map at the junctions of the unique and reiterated regions of the virus DNA S component. J Virol (1981) 3.19
Restriction endonuclease and nucleotide sequence analyses of molecularly cloned unintegrated avian tumor virus DNA: structure of large terminal repeats in circle junctions. J Virol (1982) 3.02
Neurotropic properties of pseudorabies virus: uptake and transneuronal passage in the rat central nervous system. J Neurosci (1990) 3.01
Cloning of integrated Moloney sarcoma proviral DNA sequences in bacteriophage lambda. Proc Natl Acad Sci U S A (1979) 2.98
Specific pseudorabies virus infection of the rat visual system requires both gI and gp63 glycoproteins. J Virol (1993) 2.92
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun (1994) 2.81
Characterization of a pseudorabies virus glycoprotein gene with homology to herpes simplex virus type 1 and type 2 glycoprotein C. J Virol (1986) 2.79
Olfactory inputs to hypothalamic neurons controlling reproduction and fertility. Cell (2005) 2.73
Pseudorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system. J Virol (1992) 2.69
Pseudorabies virus infection of the rat central nervous system: ultrastructural characterization of viral replication, transport, and pathogenesis. J Neurosci (1993) 2.64
The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus. J Virol (1987) 2.58
DNA sequence of an immediate-early gene (IEmRNA-5) of herpes simplex virus type I. Nucleic Acids Res (1982) 2.50
Pseudorabies virus gene encoding glycoprotein gIII is not essential for growth in tissue culture. J Virol (1986) 2.47
Two alpha-herpesvirus strains are transported differentially in the rodent visual system. Neuron (1991) 2.46
Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol (1999) 2.39
Role of envelope protein gE endocytosis in the pseudorabies virus life cycle. J Virol (1998) 2.32
A genetic analysis of the att-int-xis region of coliphage lambda. J Mol Biol (1977) 2.29
Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins. J Exp Med (1987) 2.28
Role for DNA homology in site-specific recombination. The isolation and characterization of a site affinity mutant of coliphage lambda. J Mol Biol (1983) 2.20
Pseudorabies virus expressing enhanced green fluorescent protein: A tool for in vitro electrophysiological analysis of transsynaptically labeled neurons in identified central nervous system circuits. Proc Natl Acad Sci U S A (2000) 2.18
Local modulation of plus-end transport targets herpesvirus entry and egress in sensory axons. Proc Natl Acad Sci U S A (2004) 2.17
Role of the cytoplasmic tail of pseudorabies virus glycoprotein E in virion formation. J Virol (2000) 2.17
Mutation of the YXXL endocytosis motif in the cytoplasmic tail of pseudorabies virus gE. J Virol (1999) 2.13
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun (1998) 2.12
New chromosomal location for structural genes of ribosomal proteins. Proc Natl Acad Sci U S A (1975) 2.11
COMPARISON OF THE EFFECTS OF MASSIVE BLOOD TRANSFUSIONS AND OF LIVER EXTRACT IN PERNICIOUS ANEMIA. J Clin Invest (1946) 2.09
A conserved alpha-herpesvirus protein necessary for axonal localization of viral membrane proteins. J Cell Biol (2001) 2.09
DNA sequence of the Herpes simplex virus type 2 glycoprotein D gene. Gene (1983) 2.05
Neuron-to-cell spread of pseudorabies virus in a compartmented neuronal culture system. J Virol (2005) 2.05
Characterization of the sequence-specific interaction of mouse c-myb protein with DNA. EMBO J (1990) 2.05
Pneumococcal meningitis in sickle-cell anemia. N Engl J Med (1966) 2.04
Coliphage lambdanutL-: a unique class of mutants defective in the site of gene N product utilization for antitermination of leftward transcription. J Mol Biol (1978) 2.00
Role of pseudorabies virus Us9, a type II membrane protein, in infection of tissue culture cells and the rat nervous system. J Virol (2000) 1.97
A complement receptor locus: genes encoding C3b/C4b receptor and C3d/Epstein-Barr virus receptor map to 1q32. J Immunol (1987) 1.94
Role of coliphage M13 gene 5 in single-stranded DNA production. J Mol Biol (1971) 1.93
Heterogeneity of a fluorescent tegument component in single pseudorabies virus virions and enveloped axonal assemblies. J Virol (2005) 1.92
The red plaque test: a rapid method for identification of excision defective variants of bacteriophage lambda. Virology (1976) 1.87
Pseudorabies virus glycoprotein gIII is required for efficient virus growth in tissue culture. J Virol (1988) 1.85
Transfection of Escherichia coli spheroplasts. V. Activity of recBC nuclease in rec+ and rec minus spheroplasts measured with different forms of bacteriophage DNA. J Virol (1975) 1.85
The Us9 gene product of pseudorabies virus, an alphaherpesvirus, is a phosphorylated, tail-anchored type II membrane protein. J Virol (1998) 1.84
Identification of a partial cDNA clone for the human receptor for complement fragments C3b/C4b. Proc Natl Acad Sci U S A (1985) 1.81
Analysis of pseudorabies virus glycoprotein gIII localization and modification by using novel infectious viral mutants carrying unique EcoRI sites. J Virol (1987) 1.80
Characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of gE: evidence for envelope incorporation, virulence, and neurotropism domains. J Virol (1997) 1.79
Sorting and transport of alpha herpesviruses in axons. Traffic (2001) 1.76
Cloning the spoT gene of Escherichia coli: identification of the spoT gene product. J Bacteriol (1979) 1.73
Innervation of the heart and its central medullary origin defined by viral tracing. Science (1994) 1.71
Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations. J Virol (2010) 1.71
Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. Proc Natl Acad Sci U S A (1988) 1.65
A wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses. PLoS Pathog (2011) 1.63
Making the case: married versus separate models of alphaherpes virus anterograde transport in axons. Rev Med Virol (2012) 1.63
Two steroid 21-hydroxylase genes are located in the murine S region. Nature (1985) 1.58
Identification of a restriction fragment length polymorphism by a CR1 cDNA that correlates with the number of CR1 on erythrocytes. J Exp Med (1986) 1.56
Nucleotide preferences in sequence-specific recognition of DNA by c-myb protein. Nucleic Acids Res (1991) 1.53
Two modes of pseudorabies virus neuroinvasion and lethality in mice. J Virol (2004) 1.51
Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease. J Immunol (1999) 1.50
The export pathway of the pseudorabies virus gB homolog gII involves oligomer formation in the endoplasmic reticulum and protease processing in the Golgi apparatus. J Virol (1990) 1.49
A chicken embryo eye model for the analysis of alphaherpesvirus neuronal spread and virulence. J Virol (1998) 1.48
Structure of the human B lymphocyte receptor for C3d and the Epstein-Barr virus and relatedness to other members of the family of C3/C4 binding proteins. J Exp Med (1988) 1.48
A relaxed mutant with an altered ribosomal protein L11. Mol Gen Genet (1976) 1.48
Pseudorabies virus Us9 directs axonal sorting of viral capsids. J Virol (2007) 1.48
Definition of neuronal circuitry controlling the activity of phrenic and abdominal motoneurons in the ferret using recombinant strains of pseudorabies virus. J Neurosci (2000) 1.47
Influence of infectious dose upon productive replication and transynaptic passage of pseudorabies virus in rat central nervous system. J Neurovirol (1995) 1.47
Intracellular trafficking and localization of the pseudorabies virus Us9 type II envelope protein to host and viral membranes. J Virol (1999) 1.47
The pseudorabies virus VP22 homologue (UL49) is dispensable for virus growth in vitro and has no effect on virulence and neuronal spread in rodents. J Virol (2002) 1.45
The gene encoding the gIII envelope protein of pseudorabies virus vaccine strain Bartha contains a mutation affecting protein localization. J Virol (1989) 1.44
Identification of a partial cDNA clone for the C3d/Epstein-Barr virus receptor of human B lymphocytes: homology with the receptor for fragments C3b and C4b of the third and fourth components of complement. Proc Natl Acad Sci U S A (1986) 1.42
Directional transneuronal infection by pseudorabies virus is dependent on an acidic internalization motif in the Us9 cytoplasmic tail. J Virol (2000) 1.42
Reiterated sequences within the intron of an immediate-early gene of herpes simplex virus type 1. Nucleic Acids Res (1981) 1.42
Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. J Virol (1996) 1.41
Construction of E. coli expression plasmid libraries: localization of a pseudorabies virus glycoprotein gene. J Mol Appl Genet (1984) 1.41
An immunologically active chimaeric protein containing herpes simplex virus type 1 glycoprotein D. Nature (1983) 1.40
Strand exchange in site-specific recombination. Proc Natl Acad Sci U S A (1979) 1.39
The role of CD14 in signaling mediated by outer membrane lipoproteins of Borrelia burgdorferi. J Immunol (1998) 1.38
Effect of shaking speed on the secretion of enterotoxin B by Staphylococcus aureus. Appl Microbiol (1972) 1.38
Spatiotemporal responses of astrocytes, ramified microglia, and brain macrophages to central neuronal infection with pseudorabies virus. J Neurosci (1993) 1.37
Pseudorabies virus membrane proteins gI and gE facilitate anterograde spread of infection in projection-specific neurons in the rat. J Virol (2000) 1.37